Pharmaceutical Follow-up Program for Patients with Oral Drug Treatment in Non-small Cell Lung Cancer in a Heterogeneous Health Care System

被引：1
|
作者：
Moreira, G. [1 ]
Ferreira, C. G. [1 ]
Montella, T. [1 ]
Vasconcellos, J. [1 ]
Goncalves, I. [1 ]
机构：
[1] Grp Oncoclin, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
Oral drug; target therapy; clinical pharmacist;
D O I：
10.1016/j.jtho.2019.09.161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.26
引用
收藏
页码：S1184 / S1184
页数：1
相关论文
共 50 条
  • [21] Follow-Up Update of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
    Zhang, J-T
    Gao, X.
    Liu, S-Y
    Jiao, Z.
    Dong, S.
    Pan, Y.
    Zhou, Q.
    Zhong, W-Z
    Yang, X-N
    Yi, X.
    Wu, Y-L
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S117 - S117
  • [22] False positives of an intensive postoperative follow-up for non-small cell lung cancer (NSCLC)
    Westeel, V
    Olaru, I
    Falcoz, P
    Ardizzoni, A
    Choma, D
    Dubiez, A
    Jacoulet, R
    Pugin, J
    Dalphin, J
    Depierre, A
    LUNG CANCER, 2005, 49 : S363 - S364
  • [23] FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet
    Stirling, Rob G.
    Zalcberg, John
    ANNALS OF THORACIC SURGERY, 2020, 109 (05): : 1624 - 1624
  • [24] Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment
    Colombi, Davide
    Di Lauro, Elisa
    Silva, Mario
    Manna, Carmelinda
    Rossi, Cristina
    De Filippo, Massimo
    Zompatori, Maurizio
    Ruffini, Livia
    Sverzellati, Nicola
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2013, 19 (06) : 447 - 456
  • [25] Optimal Follow Up Care for Patients with P-stage I Non-Small Cell Lung Cancer After Surgical Treatment
    Notsuda, H.
    Oshio, H.
    Tanaka, R.
    Watanabe, Y.
    Eba, S.
    Suzuki, T.
    Oishi, H.
    Sakurada, A.
    Okada, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S284 - S285
  • [26] Treatment in patients with resectable non-small cell lung cancer: A 3-month follow up study
    Mikami, I
    Akizuki, S
    Okuyama, T
    Nakano, T
    Akechi, T
    Okamura, H
    Yamawaki, S
    Uchitomi, Y
    PSYCHO-ONCOLOGY, 2000, 9 (05) : S89 - S89
  • [27] Drug treatment of metastasized non-small cell lung cancer
    Leipert, Jenny
    Hammerschmidt, Stefan
    Gessner, Christian
    PNEUMOLOGE, 2019, 16 (06): : 397 - 409
  • [28] CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy
    Ebert, W
    Muley, T
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2669 - 2672
  • [29] Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival?
    Srikantharajah, Dharshika
    Ghuman, Abeer
    Nagendran, Myura
    Maruthappu, Mahiben
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 15 (05) : 893 - 898
  • [30] Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA
    Lamont, JP
    Kakuda, JT
    Smith, D
    Wagman, LD
    Grannis, FW
    ARCHIVES OF SURGERY, 2002, 137 (08) : 935 - 938
12345